90-69-7 Usage
Description
Lobeline, the principal lobelia alkaloid, is predominantly found in Lobelia chinensis, Lobelia inflata, Campanula medium, Lobelia hassleri, and Lobelia nicotianaefolia. Historically known as Indian tobacco, Lobelia inflata has been utilized for treating respiratory ailments and asthma by American Aborigines. In the 19th-century United States, it was employed as a vomiting agent to expel toxins, earning it the nickname "vomit grass." Today, Lobelia inflata continues to be used for clearing respiratory mucus from the throat, bronchial, lung, and other areas.
Uses
Used in Pharmaceutical Industry:
Lobeline is used as a respiratory stimulant for treating respiratory diseases and conditions.
Used in Anti-smoking Products:
Lobeline's sulfate salt is utilized in antismoking tablets, aiding in smoking cessation efforts.
History
In the 1930s, the chemical synthesis process of lobeline was completed, and its
artificial synthesis was realized, which was found in Lobelia inflata from the North
American Campanulaceae. It was commonly used as a lobeline hydrochloride.
Because of its structure similar to nicotine, it was initially used for the treatment of
respiratory diseases. Further study found that lobeline can selectively excite the
carotid sinus peripheral chemoreceptors, then reflect the excitement of the medullary breathing center, and enhance respiratory function. Therefore, it is widely used
as a respiratory stimulant .Although lobeline showed similar biological activity with nicotine, its potency is
just only 1/5~1/20 of nicotine. Hence, lobeline was used as a substitute for nicotine in many smoking cessation products. However, in 1993, the Food and Drug
Administration (FDA) banned the sale of smoking cessation products containing
lobeline because it was ineffective in helping people quit smoking. However, the
research of lobeline in drug addiction still continues.
Indications
Lobeline was recorded in chemical drug and preparations as lobeline hydrochloride,
which is prepared as injection for the treatment of central respiratory inhibition
induced by a variety of reasons. In addition, it is also used for the treatment of neonatal stasis, carbon monoxide, opioid poisoning, and so on.
Health Hazard
The structure of lobeline is different fromthose of nicotine and anabasine. It does nothave a pyridine ring, similar to the lattertwo alkaloids. However, its pharmacologicaction is similar to but less potent than thatof nicotine. Like anabasine, it is a respiratorystimulant. The toxic symptoms includeincreased salivation, nausea, vomiting, diarrhea,and respiratory distress.
Pharmacology
The pharmacological effects of lobeline are extensive, mainly manifested as
nicotine-like effect. On the one hand, lobeline can selectively excite the carotid
sinus and aortic body chemoreceptors and induce reflective excitement of the respiratory center and vagus center. Lobeline showed better excitatory effect for the
respiratory inhibition caused by morphine. There is bronchiectasis effect directly
when lobeline is inhaled, hence, against pilocarpine and acetylcholine-induced tracheal contraction. When the dose increased, lobeline can directly stimulate the
respiratory center and excite vagal center (reducing heart rate) and vomiting center
in medulla oblongata. In addition, lobeline showed dual role in the regulation of
ganglion, as manifested excitement and inhibition in chronological order. Lobeline
has a zebra-like effect on the striated muscle. In addition, it also has a certain anticancer effect, as manifested by significantly inhibiting the uptake of oxygen in
mouse ascites cancer cells .
Clinical Use
It is mainly used in the treatment of (1) neonatal asphyxia, (2) suffocation caused by
carbon monoxide, (3) poisoning induced by inhalation of anesthetics and other central inhibitors (such as opioids and barbiturates), and (4) respiratory failure caused
by pneumonia, diphtheria, and other infectious diseases.
Side effects
Lobeline also showed side
effects, such as nausea, vomiting, cough, headache, palpitations, and other adverse
reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 90-69-7 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 0 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 90-69:
(4*9)+(3*0)+(2*6)+(1*9)=57
57 % 10 = 7
So 90-69-7 is a valid CAS Registry Number.
InChI:InChI=1/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3
90-69-7Relevant articles and documents
Synthesis method of lobeline
-
, (2019/02/04)
The invention discloses a synthesis method of lobeline and belongs to the technical field of organic synthesis. The synthesis method comprises the following steps: sequentially carrying out ring opening reaction, oxidization reaction, dehydration reaction, addition reaction, reduction reaction, protection reaction, substitution reaction, hydrolysis reaction, coupling reaction and hydrolysis ring closing reaction to prepare 2-[(2R,6S)-6-[(2S)-2-hydroxyl-2-phenethyl]-1-methylpiperidine]-1-acetophenone. According to the synthesis method disclosed by the invention, a whole technological route is simple, raw materials are cheap and easy to obtain, the cost is low, reaction conditions are mild, the operation is simple, the chiral purity is high and the yield is high; a chiral center is synthesized through simple chemical reaction and an expensive chiral catalyst is not used, so that the cost is reduced; in the whole technological route, the raw materials are cheap and easy to obtain, the cost is low, the technology is simple, the reaction conditions are mild, the operation is simple and the total yield is high.
2-[(2R, 6S)-6-[(2S)-2-hydroxy-2-phenethyl]-1-pipecoline]-1-hypnone synthesis method
-
Paragraph 0045; 0046; 0047; 0054; 0055, (2017/06/02)
The invention discloses a 2-[(2R, 6S)-6-[(2S)-2-hydroxy-2-phenethyl]-1-pipecoline]-1-hypnone synthesis method, and belongs to the field of organic synthesis. (1S, 2S)-1, 2-diphenyl diaminoethane serving as a raw material is subjected to acylation, substitution and the like to prepare chiral amine catalysts. A main route totally includes two steps: synthesizing glutaraldehyde, benzoyl acetic acid and methylamine hydrochloride to form cis-lobelanine; performing asymmetric selective reduction synthesis of 2-[(2R, 6S)-6-[(2S)-2-hydroxy-2-phenethyl]-1-pipecoline]-1-hypnone under mild reaction conditions and under the action of the catalysts. The raw material in the whole process route is cheap and easy to obtain, the catalysts can be recycled and can continue to be used, and the synthesis method is low in cost, simple in process, mild in reaction condition, convenient in operation and high in total yield.
Synthesis of (-)-lobeline via enzymatic desymmetrization of lobelanidine
Chenevert, Robert,Morin, Pierre
experimental part, p. 1837 - 1839 (2009/05/26)
The bioactive alkaloid (-)-lobeline was synthesized via the stereoselective acylation (desymmetrization) of meso-lobelanidine by vinyl acetate in the presence of Candida antarctica lipase B.